This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Immunohistochemistry Market

Market Insights on Immunohistochemistry covering sales outlook, demand forecast & up-to-date key trends

Immunohistochemistry Market by Product, Application, End-use & Region - Forecast 2022 - 2032

Immunohistochemistry Market Outlook (2022-2032)

[309 Pages Report] The immunohistochemistry market is projected to be valued at US$ 2.05 Bn in 2022 and is anticipated to reach US$ 4.59 Bn by 2032, with a rapid CAGR of 8.4% from 2022 to 2032.

“The immunohistochemistry market share is anticipated to be significantly driven during the projected period by rising automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions. The demand for immunohistochemistry in disease diagnosis has increased significantly due to improvements in IHC methods.”

Attributes

Details

Immunohistochemistry Market CAGR (2022-2032)

8.4%

Immunohistochemistry Market Value (2022)

US$ 2.05 Bn

Immunohistochemistry Market Value (2032)

US$ 4.59 Bn

The immunohistochemistry market share is likely to grow due to the increase in patients with cancer, infectious diseases, and cardiovascular disorders where immunohistochemistry is utilized for diagnosis.

The alarming rate at which infectious diseases are spreading is a challenge for medical professionals in the development of drugs for such unidentified diseases, and the rise in demand for immunohistochemistry for such diseases is anticipated to drive the immunohistochemistry market growth.

The International Diabetes Federation said that 463 million people aged 20 to 79 worldwide have diabetes as of 2019, and that number is expected to reach nearly 700 million by the year 2045.

Increased R&D in immunohistochemistry-based techniques is anticipated to contribute to the market's expansion in the ensuing years. The adoption of immunohistochemistry is expected to grow as a result of the surge in interest in living a higher quality life and the rise in healthcare spending.

Furthermore, immunohistochemistry market outlook is expected to grow due to the rising frequency of chronic disorders. The demand for immunohistochemistry is projected to expand at a faster rate thanks to the growing preference for value-based healthcare solutions.

In addition, the adoption of immunohistochemistry is anticipated to expand throughout the projected period due to the increase in the incidence and prevalence of cancer and other chronic diseases, where proteins are predicted to play a key role. In the short term, unfavorable reimbursement regulations are anticipated to restrain the immunohistochemistry market expansion.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Immunohistochemistry Market Dynamics?

The ageing population is anticipated to have a positive impact on the development of the immunohistochemistry (IHC) market size in both established and developing regions. T

The prevalence of age-related disorders is anticipated to rise dramatically with the worldwide geriatric population's rapid growth, propelling the demand for immunohistochemistry during the forecast period.

In 2019, there were 54 million senior persons living in the US, according to the OECD. Other wealthy nations have sizable and expanding senior populations as well. The chance of contracting diseases rises proportionately with age.

Therefore, it is anticipated that the prevalence of various diseases is likely to rise globally as the senior population grows. This is thought to be a major element propelling the adoption of immunohistochemistry and the overall market for diagnostic applications.

The rise in the number of people with diabetes mellitus has prompted concerns about early detection and a focus on treatments for the condition. Therefore, the immunohistochemistry market share is anticipated to grow during the projected time due to the rise in diabetic patients.

The usage of personalized medicine is anticipated to grow in the future due to its extraordinary efficacy in treating non-small-cell lung cancer patients. This method of choosing a course of treatment is backed by immunohistochemistry procedures, boosting the adoption of immunohistochemistry throughout 2032.

The demand for immunohistochemistry is rising as it carries out the most thorough and precise histological subtyping of malignancies (supported by predictive immunohistochemistry and the assessment of relevant biomarkers).

The increased accessibility of immunohistochemical assays is a beneficial substitute and addition to molecular testing that identifies mutant proteins, such as BRAF V600E and IDH1 R132H.

The adoption of immunohistochemistry is projected to rise as these methods are useful new instruments in the treatment of cancer in the current era since they are highly reproducible, involve a manageable level of technical and interpretive complexity, and are substantially less expensive.

Multiplex and mutation-specific immunohistochemical tests are some of the latest trends in immunohistochemistry market that have increased their usefulness in the setting of personalized medicine and targeted therapy.

However, more new developments in immunohistochemistry market, such multiplexed IHC, enable multiparametric and in-depth analysis from a single tissue segment by applying sophisticated mass spectrometric detection techniques.

The tagged fluorescence detection-based approach presents technological difficulties that are addressed by multiplexed IHC, boosting immunohistochemistry market revenue.

What are the Challenges in the Immunohistochemistry Market?

As cancer is becoming more common, there is a large increase in the demand for immunohistochemistry and pathology services for clinical applications. Most of the examinations carried out on cancer patients use histopathology technology.

However, these laboratories are severely short on trained personnel. A tiny number of histopathologists are being trained, and many histopathologists have reached retirement age. However, with a limited staff, laboratories are under pressure to process a growing number of specimens. As a result, these factors combined are anticipated to act as a challenge in the immunohistochemistry market.

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Comparative View of Adjacent Immunohistochemistry Market

Immunohistochemistry Market:

Attributes

Immunohistochemistry Market

CAGR (2022-2032)

8.4%

Market Value (2032)

US$ 4.59 Bn

Growth Factor

The growing elderly population and the ensuing rise in chronic and infectious disease prevalence are the main drivers of market expansion.

Opportunity

Multiplex and mutation-specific immunohistochemistry tests are significant advances that have boosted value in the context of targeted therapy and personalised medicine.

Key Trends

The sensitive identification of many proteins in the same sample as well as the accessibility of the detection of protein-protein interactions are two examples of recent improvements in the IHC technology.

Immunology Market:

Attributes

Immunology Market

CAGR (2022-2032)

8.1%

Market Value (2032)

US$ 171 Bn

Growth Factor

The important elements driving the growth of the global market are the increased awareness of immunological diseases and the rising frequency of immunological disorders caused by environmental factors.

Opportunity

For patients to receive improved treatment outcomes, current market players operating on the global market concentrate on ongoing innovation and product portfolio upgrades.

Key Trends

Biosimilars, the highly similar duplicates of biological pharmaceuticals, are being introduced to the market as a result of the increased demand for biological drugs as a result of their successful clinical use.

Immuno-Oncology Therapy Market:

Attributes

Immuno-Oncology Therapy Market

CAGR (2022-2032)

12%

Market Value (2032)

US$ 43.63 Bn

Growth Factor

The global immuno-oncology market has expanded as a result of the rising demand for cutting-edge immuno-oncology treatments.

Opportunity

Involvement of numerous businesses in the development of companion diagnostics and the pursuit of regulatory approval for usage in conjunction with these immuno-oncology medicines to offer lucrative opportunities in the market.

Key Trends

Recent developments in drug discovery and development highlight the promising potential of immuno-oncology therapy for the treatment of cancer in the future.

The demand for immunochemistry is rising as these techniques don't need pricey apparatus or a lot of time-consuming, destructive sample preparation. The majority of immunochemical techniques rely on straightforward photo, fluoro, or luminometric detection.

The adoption of immunochemistry in clinical diagnostics is rising as these approaches have quickly supplanted chromatographic ones because they enable quick identification of antibodies linked to particular diseases, hormones, disease biomarkers, and medications.

Enzyme-linked immunosorbent assays (ELISAs), immunochromatography in the form of lateral-flow devices like dip-sticks and test strips, and Western Blot assays used to interpret data from protein analysis with gel electrophoresis are the most frequently used assays in clinical immunochemistry.

These factors are combinedly anticipated to boost the immunochemistry market size during the forecast period.

Additionally, it is employed in environmental analysis and the evaluation of food safety, and the target chemical structures cover the broadest range of molecular weight, around hundreds of kilo Dalton (kD). Additionally, immunochemical create antibody assays for the toxins of cholera, anthrax, and diphtheria.

Segmentation Outlook for the Immunohistochemistry Market

Which Segment is Likely to Lead the Immunohistochemistry Market by Product?

Due to the crucial role that antibodies play in illness diagnosis and medication testing; the antibodies segment dominated the immunochemistry market in 2021 and accounted for the highest part of more than 41 percent of the global revenue.

In terms of usage rate, monoclonal antibodies and related products—such as Fc-fusion, antibody fragments, and antibody-drug conjugates—have taken the lead. The antibodies are used in a variety of fields, including neuropathology, hematopathology, and pathology. During the projection period, the kits category is expected to grow at the fastest CAGR.

Which Segment is Anticipated to Dominate the Immunohistochemistry Market by Application?

Approximately 70 percent of revenue was accounted for by the diagnostics application sector in 2021, and it is projected that this segment is likely to lead during the forecast period.

Numerous chronic disorders, including cancer, cardiovascular diseases, viral diseases, diabetes mellitus, autoimmune diseases, and nephrological diseases, can be diagnosed with immunohistochemistry tests. Furthermore, it is projected that the diagnostics market is likely to be driven by the rising prevalence of chronic disorders.

Which Segment is Projected to Lead the Immunohistochemistry Market by End-use?

More than 71 percent of total revenue was generated by the hospitals and diagnostic laboratories category in 2021, which dominated the immunochemistry market. This immunochemistry market expansion is related to the large number of IHC tests performed in medical facilities.

Furthermore, the need for hospitals with cutting-edge facilities has grown as a result of the healthcare sector's ongoing changes. In consequence, it is anticipated that this factor is likely to increase this segment's revenue flow.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Which Region is Leading in the Immunohistochemistry Market?

In 2021, North America dominated the immunochemistry market, contributing more than 39 percent of global sales.

The presence of significant market participants, the ease with which IHC solutions are accessible, the increased use of technologically advanced IHC instruments, and the arrival of newer IHC solutions are important factors influencing the growth of the regional immunochemistry market.

What is the Growth Outlook of Acia Pacific Immunohistochemistry Market?

During the forecast period, Asia Pacific is anticipated to experience the fastest CAGR. The global players increased geographic presence in the Asian markets is mostly to thank for this.

Additionally, a huge patient base in nations like China and India offers a high number of clinical subjects for IHC R&D tests, which boosts income.

This is a result of developments in the biotechnology field, which raised the demand for antibodies in scientific research. The expansion of immunochemistry market in the region is further aided by better government support for biotechnology research and the rise of China and India as important hubs for clinical research.

The expansion of the clinical research organization (CRO) market is being fueled by the availability of infrastructure facilities and inexpensive labor. The demand for immunochemistry in the area is thus rising.

Competition Landscape of Immunohistochemistry Market

The industry's key players are developing cutting-edge goods that are expected to fuel immunohistochemistry market expansion. The introduction of these clinical diagnostic markers might aid the immuno-oncology field in advancing early medication development for the treatment of cancer. During the projection period, the immunohistochemistry market is anticipated to expand at a faster rate thanks to the development in R&D.

How is the Start-up Ecosystem in the Immunohistochemistry Market?

Startups in immunohistochemistry industry are focusing more on technological developments in accordance with current needs. In the upcoming years, the market is expected to grow due to the introduction of new products in the immunohistochemistry sector to address the problems mentioned before.

For instance, Lunaphore Technologies SA, which is renowned for its commitment to developing next-generation tools for cancer research and tissue diagnostics, announced the release of LabSat in February 2019. The system has an automated reagent delivery mechanism and is designed to have a single slide. The product is made to enable more accurate tissue staining, which cuts down on the amount of time the sample needs to be incubated.

Key Players in the Immunohistochemistry Market

Recent Developments in the Immunohistochemistry Market

  • For solid tumours that are lacking in the MMR pathway, Roche's VENTANA MMR RxDx companion diagnostic test was given FDA approval in August 2021. The test identifies people who qualify for JEMPERLI, GSK's anti-PD1 immunotherapy.
  • For its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA, Agilent got a CE-IVD mark in Europe in August 2021.
  • The ONCORE Pro, a fully automated in vitro diagnostic benchtop system for In-situ Hybridization (ISH) and IHC applications, was introduced by Biocare Medical LLC in January 2021.
  • Abcam and Shuwen Biotech (Shuwen) formed a strategic partnership in January 2021 to create and market Companion Diagnostics (CDx). According to the contract, Abcam will give Shuwen Biotech recombinant rabbit monoclonal antibodies for additional immunohistochemistry research.

Key Segments

By Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining System
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

By Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

By End-use:

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Frequently Asked Questions

Immunohistochemistry market is projected to have a CAGR of 8.4% through 2032.

North America is the leading region in the immunohistochemistry market.

The hospitals and diagnostic laboratories segment is expected to dominate the market.

Immunohistochemistry market is predicted to grow 4.59 Bn by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        5.3.1. Reagents

            5.3.1.1. Histological Stains

            5.3.1.2. Blocking Sera and Reagents

            5.3.1.3. Chromogenic Substrates

            5.3.1.4. Fixation Reagents

            5.3.1.5. Stabilizers

            5.3.1.6. Organic Solvents

            5.3.1.7. Proteolytic Enzymes

            5.3.1.8. Diluents

        5.3.2. Antibodies

            5.3.2.1. Primary Antibodies

            5.3.2.2. Secondary Antibodies

            5.3.2.3. Slide Scanners

        5.3.3. Equipment

            5.3.3.1. Slide Staining System

            5.3.3.2. Tissue Microarrays

            5.3.3.3. Tissue Processing Systems

            5.3.3.4. Slide Scanners

            5.3.3.5. Other Equipments

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        7.2.1. By Country

            7.2.1.1. U.S.

            7.2.1.2. Canada

        7.2.2. By Product Type

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Product Type

    7.4. Key Takeaways

8. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Product Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

    8.4. Key Takeaways

9. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. U.K.

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Product Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

    9.4. Key Takeaways

10. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Product Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

    10.4. Key Takeaways

11. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Product Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

    11.4. Key Takeaways

12. Key Countries Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2021

            12.1.2.1. By Product Type

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2021

            12.2.2.1. By Product Type

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2021

            12.3.2.1. By Product Type

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2021

            12.4.2.1. By Product Type

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2021

            12.5.2.1. By Product Type

    12.6. U.K.

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2021

            12.6.2.1. By Product Type

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2021

            12.7.2.1. By Product Type

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2021

            12.8.2.1. By Product Type

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2021

            12.9.2.1. By Product Type

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2021

            12.10.2.1. By Product Type

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2021

            12.11.2.1. By Product Type

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2021

            12.12.2.1. By Product Type

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2021

            12.13.2.1. By Product Type

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2021

            12.14.2.1. By Product Type

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2021

            12.15.2.1. By Product Type

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2021

            12.16.2.1. By Product Type

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2021

            12.17.2.1. By Product Type

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2021

            12.18.2.1. By Product Type

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2021

            12.19.2.1. By Product Type

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Product Type

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Abcam Plc

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. Agilent Technologies, Inc.

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. Bio SB

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. Bio-Rad Laboratories, Inc.

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. Cell Signalling Technology, Inc.

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. Danaher Corporation

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. F. Hoffman-La Roche Ltd

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. Merck KGaA

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. PerkinElmer, Inc.

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Thermo Fisher Scientific Inc.

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 03: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 04: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 05: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 06: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 07: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 08: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 09: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 11: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Middle East and Africa Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Nikhil Kaitwade
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Value (US$ Mn) by Product Type, 2022-2032

Figure 02: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 03: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 04: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 05: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 06: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 07: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 08: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 09: Global Market Attractiveness by Product Type, 2022-2032

Figure 10: Global Market Attractiveness by Region, 2022-2032

Figure 11: North America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 12: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 13: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 16: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 17: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 18: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 19: North America Market Attractiveness by Product Type, 2022-2032

Figure 20: North America Market Attractiveness by Country, 2022-2032

Figure 21: Latin America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 22: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 23: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 26: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 27: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 29: Latin America Market Attractiveness by Product Type, 2022-2032

Figure 30: Latin America Market Attractiveness by Country, 2022-2032

Figure 31: Europe Market Value (US$ Mn) by Product Type, 2022-2032

Figure 32: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 33: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 36: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 37: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 38: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 39: Europe Market Attractiveness by Product Type, 2022-2032

Figure 40: Europe Market Attractiveness by Country, 2022-2032

Figure 41: Asia Pacific Market Value (US$ Mn) by Product Type, 2022-2032

Figure 42: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 43: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 46: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 49: Asia Pacific Market Attractiveness by Product Type, 2022-2032

Figure 50: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 51: Middle East and Africa Market Value (US$ Mn) by Product Type, 2022-2032

Figure 52: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 59: Middle East and Africa Market Attractiveness by Product Type, 2022-2032

Figure 60: Middle East and Africa Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Chemicals & Materials Insights

View Reports

Recommendations

Healthcare

Immunostimulants Market

Published : July 2022

Healthcare

Autoimmunity Immunoassay Market

Published : April 2017

Healthcare

Immunochemistry Products Market

Published : March 2022

Healthcare

Immunochemistry Analyzer Market

Published : March 2022

Google translate

Immunohistochemistry Market